Blood molecules may unlock secrets of pancreatic cancer
NCT ID NCT04406831
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at tiny molecules called microRNA in the blood of people with advanced pancreatic cancer. Researchers want to see if these molecules can help diagnose the disease earlier, predict how it will progress, and show whether treatment is working. The study will follow 200 participants, including a control group, with monthly blood draws for the cancer group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test for earlier detection of pancreatic cancer and better prediction of how patients will respond to treatment.
- What could go wrong
- This is an early observational study, not a treatment trial. The findings may not translate into a reliable diagnostic test or apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER STAGE III are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nuvance Health
RECRUITINGNorwalk, Connecticut, 06856, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Blood and gut clues may flag pancreatic cancer risk early
- Can a new imaging trick spot pancreatic cancer without a biopsy?
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a pill outsmart Tumors' defenses?
- A sound wave that could expose hidden pancreatic cancer?